Cleared Traditional

K230142 - Epi-Stop Nasal Gel/epistaxis pack (FDA 510(k) Clearance)

Mar 2023
Decision
63d
Days
Class 1
Risk

K230142 is an FDA 510(k) clearance for the Epi-Stop Nasal Gel/epistaxis pack. This device is classified as a Splint, Intranasal Septal (Class I - General Controls, product code LYA).

Submitted by Biomed Ent, Inc. (San Antonio, US). The FDA issued a Cleared decision on March 22, 2023, 63 days after receiving the submission on January 18, 2023.

This device falls under the Ear, Nose, Throat FDA review panel. Regulated under 21 CFR 874.4780.

Submission Details

510(k) Number K230142 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 18, 2023
Decision Date March 22, 2023
Days to Decision 63 days
Submission Type Traditional
Review Panel Ear, Nose, Throat (EN)
Summary Summary PDF

Device Classification

Product Code LYA - Splint, Intranasal Septal
Device Class Class I - General Controls
CFR Regulation 21 CFR 874.4780